Have a personal or library account? Click to login
New Modalities in Knee Osteoarthritis Treatment Using Autologous Bone Marrow-Derived Mononuclear Cells Cover

New Modalities in Knee Osteoarthritis Treatment Using Autologous Bone Marrow-Derived Mononuclear Cells

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 72 (2018): Issue 4 (August 2018)
By: Valdis Gončars,  Konstantīns Kalnbērzs,  Ēriks Jākobsons,  Ieva Briede,  Kristaps Blūms,  Kristaps Ērglis,  Mārtiņš Ērglis,  Liene Patetko,  Indriķis Muižnieks and  Andrejs Ērglis  
Open Access
|Aug 2018

Metrics

DOI: https://doi.org/10.2478/prolas-2018-0066 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 207 - 215
Submitted on: Sep 18, 2017
|
Accepted on: Nov 23, 2017
|
Published on: Aug 22, 2018
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
knee osteoarthritis,
mesenchymal stem cells,
hyaluronic acid,
bone marrow mononuclear cells,
regenerative therapy
Related subjects:
General interest,
Mathematics,
General mathematics

© 2018 Valdis Gončars, Konstantīns Kalnbērzs, Ēriks Jākobsons, Ieva Briede, Kristaps Blūms, Kristaps Ērglis, Mārtiņš Ērglis, Liene Patetko, Indriķis Muižnieks, Andrejs Ērglis, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 72 (2018): Issue 4 (August 2018)Next article